Back
Corvus Pharmaceuticals Stock Price Chart
Unlock the power of "two-minute trades"
Learn how today!
Sell
27
CRVS
Corvus Pharmaceuticals
Last Price:
$5.35
Seasonality Move:
-3.05%
7 Day Trial
ALL ACCESS PASS
$
7
Free Stock Analysis: See What Your Stock is Really Worth
Analyze Any Stock Free-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CRVS is experiencing slight selling pressure.
Corvus Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 5.56 | Buy |
| 20-day SMA: | 6 | Sell |
| 50-day SMA: | 7.63 | Sell |
| 200-day SMA: | 4.28 | Buy |
| 8-day EMA: | 5.65 | Sell |
| 20-day EMA: | 6.08 | Sell |
| 50-day EMA: | 6.68 | Sell |
| 200-day EMA: | 5 | Buy |
Corvus Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.57 | Sell |
| Relative Strength Index (14 RSI): | 41.35 | Sell |
| Chaikin Money Flow: | -129616 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (5.07 - 7.79) | Sell |
| Bollinger Bands (100): | (4.68 - 8.28) | Sell |
Corvus Pharmaceuticals Technical Analysis
| Dec 24 | Dec 26 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | Jan 6 | Jan 7 | Jan 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | Jan | |||||||||
| 24 | 26 | 27 | 30 | 31 | 02 | 03 | 06 | 07 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Corvus Pharmaceuticals Stock
Is Corvus Pharmaceuticals Stock a Buy?
-
Corvus Pharmaceuticals share price is 5.65 while CRVS 8-day simple moving average is 5.56, which is a Buy signal.
-
The stock price of CRVS is 5.65 while Corvus Pharmaceuticals 20-day SMA is 6.00, which makes it a Sell.
-
Corvus Pharmaceuticals 50-day simple moving average is 7.63 while CRVS share price is 5.65, making it a Sell technically.
-
CRVS stock price is 5.65 and Corvus Pharmaceuticals 200-day simple moving average is 4.28, creating a Buy signal.
CRVS Technical Analysis vs Fundamental Analysis
Sell
27
Corvus Pharmaceuticals (CRVS)
is a Sell
Is Corvus Pharmaceuticals a Buy or a Sell?
-
Corvus Pharmaceuticals stock is rated a SellThe current Corvus Pharmaceuticals [CRVS] share price is $5.65. The Score for CRVS is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
Corvus Pharmaceuticals Stock Info
Market Cap:
341.8M
Price in USD:
5.65
Share Volume:
388.8K
Corvus Pharmaceuticals 52-Week Range
52-Week High:
10.00
52-Week Low:
1.30
Sell
27
Corvus Pharmaceuticals (CRVS)
is a Sell
Corvus Pharmaceuticals Share Price Forecast
-
What is the Corvus Pharmaceuticals stock price today?The Corvus Pharmaceuticals stock price is 5.65 USD today.
-
Will CRVS stock go up or go down?Corvus Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators
-
Is Corvus Pharmaceuticals overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Corvus Pharmaceuticals is overvalued.
Is Corvus Pharmaceuticals Stock a Buy?
-
Corvus Pharmaceuticals share price is 5.65 while CRVS 8-day exponential moving average is 5.65, which is a Sell signal.
-
The stock price of CRVS is 5.65 while Corvus Pharmaceuticals 20-day EMA is 6.08, which makes it a Sell.
-
Corvus Pharmaceuticals 50-day exponential moving average is 6.68 while CRVS share price is 5.65, making it a Sell technically.
-
CRVS stock price is 5.65 and Corvus Pharmaceuticals 200-day simple moving average is 5.00, creating a Buy signal.
Fundamental Analysis of Corvus Pharmaceuticals
Is Corvus Pharmaceuticals a good investment?
-
Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.46 per share, and a decrease next year of $0.10 per share.
Technical Analysis of Corvus Pharmaceuticals
Should I short Corvus Pharmaceuticals stock?
-
CRVS Moving Average Covergence Divergence (MACD) indicator is -0.57, suggesting Corvus Pharmaceuticals is a Sell
-
Corvus Pharmaceuticals Relative Strength Index (RSI) is 41.35, which suggest Corvus Pharmaceuticals is oversold
-
The Bollinger Bands (25) for Corvus Pharmaceuticals is (5.07 - 7.79), which suggest Corvus Pharmaceuticals is a Sell
-
The Bollinger Bands (100) for Corvus Pharmaceuticals is (4.68 - 8.28), which suggest Corvus Pharmaceuticals is a Sell
* Corvus Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.